CASK is a gene that provides instructions for making a protein essential to brain development. When this gene has a mutation, it causes a group of rare neurological conditions known collectively as CASK-related disorders. These conditions primarily affect brain growth, movement, vision, hearing, and intellectual development, and they range from a severe form involving an abnormally small head and underdeveloped brain structures to a milder form centered on intellectual disability.
What the CASK Gene Does
The CASK protein (short for calcium/calmodulin-dependent serine protein kinase) is found mainly in neurons. It acts as a regulator, switching other genes on or off during brain development. It also helps control the movement of neurotransmitters and charged particles that neurons use to communicate with each other. Beyond general brain wiring, the CASK protein interacts with another protein involved in building the nerve network that controls eye movement.
Because CASK plays such a central role in how the brain forms and how neurons signal, mutations that reduce or eliminate the protein’s function have wide-reaching effects on the nervous system.
The Two Main Forms of CASK Disorder
CASK-related disorders fall on a spectrum, but clinicians recognize two primary presentations.
MICPCH (microcephaly with pontine and cerebellar hypoplasia) is the more severe form. It results from mutations that essentially knock out the CASK gene’s function. The hallmark is progressive microcephaly: about two thirds of affected girls are born with a normal or low-normal head size, but the head fails to keep pace with body growth, typically becoming severely small within the first four months of life. Brain imaging shows underdevelopment of the brainstem and cerebellum, the structures responsible for balance, coordination, and relaying signals between the brain and body. The cerebellar hemispheres are often noticeably uneven in size.
X-linked intellectual disability (XLID) with or without nystagmus is the milder form. It results from mutations that partially reduce CASK function rather than eliminating it. Intellectual disability ranges from mild to severe, and some affected females have normal intelligence. Rapid, involuntary eye movements (nystagmus), seizures, and tremors may also be present.
How MICPCH Affects Development
Children with MICPCH face significant developmental challenges. Most affected girls gain head control and begin making eye contact somewhere between 2 and 24 months of age. Sitting independently typically happens between 7 and 36 months, but only 20 to 25 percent ever learn to walk, usually between 18 months and 6 years. Language is nearly absent in most cases; a few children learn individual words, and in rare instances, short two-word sentences.
Intellectual disability is severe in nearly all affected females. In males, the picture is generally even more serious. All affected boys in documented cases have had severe to profound developmental delay, and some show no developmental progress at all. The most severely affected males also develop a serious seizure condition called epileptic encephalopathy.
Seizures and Epilepsy
Epilepsy is a frequent comorbidity. Nearly 40 percent of individuals with MICPCH develop seizures by age ten. In one study of 34 patients with CASK mutations, half experienced epileptic seizures. The most common seizure type was spasms, affecting about a third of the group, followed by generalized seizures. Seizures in CASK disorders tend to appear later than in some other genetic epilepsies, but they are often difficult to control. Over half of patients with epilepsy in that study had drug-resistant seizures, meaning standard medications did not fully manage them.
Vision and Hearing Problems
Sensory impairments are common across CASK disorders. Sensorineural hearing loss, caused by nerve damage in the inner ear, is a core feature of MICPCH and also occurs in the milder form. On the vision side, several abnormalities can overlap: underdevelopment of the optic nerves, breakdown of the light-sensing tissue at the back of the eye, and eyes that don’t align in the same direction (strabismus). Some children also develop optic atrophy, a progressive weakening of the optic nerve. These sensory issues compound the communication and learning difficulties that are already present.
Other Physical Features
MICPCH often produces a recognizable pattern of facial features, including arched eyebrows, a short broad nose, a lengthened space between the nose and upper lip, a protruding upper jaw, a short chin, and large ears. Children typically have low muscle tone in the trunk but increased stiffness and tightness in the arms and legs, a combination that makes both sitting and movement difficult. Involuntary muscle tensing (dystonia) adds another layer of motor difficulty.
Additional problems seen across the spectrum include feeding difficulties, poor weight gain, constipation, gastroesophageal issues, short stature, and in boys, undescended testes. Behavioral features such as self-biting, hand flapping, sleep disturbances, and autism spectrum traits have also been reported.
Why It Affects Males and Females Differently
The CASK gene sits on the X chromosome. Because females have two X chromosomes, they always retain one working copy of the gene even when the other carries a mutation. Males have only one X chromosome, so a loss-of-function mutation leaves them with no working copy at all. This is why the severe MICPCH form in males usually involves a special situation: the mutation is present in only some of the body’s cells (called mosaicism), or the particular variant only partially disrupts function. Boys who carry a complete loss-of-function mutation throughout all their cells tend to have the most severe outcomes, including profound developmental delay and serious epilepsy.
The milder XLID form in males is typically caused by mutations that reduce CASK activity without eliminating it entirely.
How CASK Disorders Are Diagnosed
Diagnosis usually begins when a young child shows progressive microcephaly, severe developmental delay, or a combination of intellectual disability with vision or hearing problems. Brain MRI is a key step: it reveals the characteristic underdevelopment of the brainstem and cerebellum. Unlike some other forms of cerebellar underdevelopment where the central portion (the vermis) is relatively spared, in CASK-related MICPCH both the vermis and the hemispheres are small, and the hemispheres are often asymmetric.
Confirmation comes through genetic testing. Clinicians typically use broad gene panels for intellectual disability or whole-exome sequencing, which scans the protein-coding portions of a child’s DNA. These tests can identify the specific CASK mutation and help distinguish between loss-of-function variants (associated with MICPCH) and partial-function variants (associated with the milder XLID form).
Managing Symptoms
There is no treatment that corrects the underlying genetic mutation. Management focuses on supporting each child’s specific needs. For feeding difficulties and poor weight gain, feeding therapy is a first step; some children require a gastrostomy tube for nutrition when swallowing problems persist. A low threshold for swallowing studies is recommended if there are any signs of choking or aspiration.
Physical and occupational therapy address the combination of low trunk tone and limb stiffness, with regular stretching to help prevent joint contractures. Positioning devices, mobility aids, and adaptive equipment become important as children grow. For seizures, a neurologist works through available medications, though families should be aware that drug resistance is common and seizure control may require trying multiple approaches. Hearing aids or cochlear implants may be considered for sensorineural hearing loss, and regular ophthalmology follow-up helps track and manage evolving vision issues.